WHO WE SERVE / Mid-Market PHARMACEUTICALS

Enterprise-Grade RBQM for Lean Clinical Teams

Mid-market Sponsors carry the same ICH E6(R3) obligations as the world's largest pharmaceutical companies. The difference is team size, budget, and how much you can afford to get wrong. CluePoints delivers regulatory-grade Risk-Based Quality Management (RBQM) and clinical data oversight designed for lean organizations that need to move quickly, operate efficiently, and compete on submission quality without building an enterprise-scale internal oversight function from the ground up.

Connect with an Expert
Explore the Platform

Top 20

global pharma companies use CluePoints

500+

enterprise studies actively monitored

40%

reduction in
monitoring costs

3x

faster risk signal identification

Challenges We Solve for Mid-Market Sponsors

Lean teams and tighter resources do not change the regulatory obligation. CluePoints is built to bridge that gap, from strategy through execution.

Same Obligations, Fewer Internal Resources

Managing quality across dozens of simultaneous studies, multiple CRO partners, and varied EDC platforms creates blind spots. CluePoints unifies risk signals across your entire portfolio in one environment, so you see what matters before regulators do.

Sponsor Accountability Across CRO-Led Programs

Mid-market Sponsors frequently rely heavily on one or two primary CROs, but the Sponsor remains accountable to regulators for the quality of oversight. CluePoints provides an independent, vendor-agnostic oversight layer above CRO systems, giving Sponsors their own view of quality risk across CRO-led programs without disrupting established partner workflows.

Inspection Exposure Without an Enterprise Inspection Team

Without a dedicated RBQM infrastructure, mid-market Sponsors face disproportionate inspection risk relative to their team's capacity to prepare. CluePoints captures the complete oversight evidence thread automatically, from CtQ mapping through signal resolution, so inspection readiness is a byproduct of routine practice rather than a pre-audit scramble.

Complex Multi-System Technology Landscapes

Mid-market Sponsors frequently have mixed EDC, CTMS, and CRO technology stacks with no single system providing a unified risk view. CluePoints' vendor-agnostic ingestion unifies risk signals from every source above and between existing tools without forcing a platform change or CRO system replacement.

 

The Complete Clinical Intelligence Platform

A unified RBQM and clinical data oversight platform built for mid-market pace and mid-market economics.

Risk-Based Quality Management (RBQM)

Regulatory-grade RBQM for lean teams: Central Monitoring Platform (CMP) analytics and Site Profile & Oversight Tool (SPOT) site prioritization deliver ICH E6(R3)-aligned oversight without the enterprise overhead or a large internal RBQM function.

Explore

Intelligent Medical
Coding (IMC)

Cut manual coding effort by approximately 50% and maintain coding consistency across studies as your pipeline grows, without scaling the coding team proportionally.

Explore

Medical & Safety
Review (MSR)

Structured, validated medical and safety review with fast deployment economics: key-variable mapping enables compliant review in days, with approximately 80% configuration reuse within the same therapeutic area.

Explore

Intelligent Query
Detection (IQD)

Release Data Management (DM) capacity from manual listing review with agentic AI that delivers 80% or greater precision, keeping your team in control while removing the investigation burden that slows database lock.

Explore

Consulting
& Services

Right-sized RBQM framework design, CtQ mapping, and implementation support that gets your program running quickly and builds genuine internal capability, not just platform familiarity.

Explore

“CluePoints gives us access to view data in ways we otherwise can't and the trends coming out of it are giving us opportunity to research and investigate”

Global Senior Study Lead - Top 20 Pharmaceutical Company

"The robust SMART engine and supporting features help achieve our Central Monitoring objectives effectively and efficiently."

Associate Director, RBQM Data Enablement, Clinical Data Solutions - Leading Pharmaceutical Company

"Excellent knowledge by the staff, willingness to understand therapeutic details, phenomenal technology."

Associate Director, Clinical Data Science - Top 10 Pharmaceutical Company

“Risk Based Quality Management is no more an option but a standard to operate your clinical trials: CluePoints contributed to build this new landscape and now CluePoints pioneer next step to drive your monitoring activities”

RBQM Leader - Top 10 Pharmaceutical Company

"CluePoints is an industry leading RBQM platform. I would have no reservations about recommending."

RBQM Leader - Global Pharmaceutical Company

Let's Build Your RBQM Capability

Talk to a specialist who understands mid-market scale and how to deliver regulatory-grade RBQM without building an enterprise function.

Speak with an Expert
View Our Case Studies